TORL BioTherapeutics Funding: $450M Raised, Series C (2025)

TORL BioTherapeutics funding overview

TORL BioTherapeutics is a Biotech company based in Culver City, California. TORL BioTherapeutics has raised $450M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Series C announced in October 2025. The round record for TORL BioTherapeutics runs through 2025; nothing later has been disclosed. Investors on record include Goldman Sachs Asset Management, Bristol Myers Squibb, Deep Track Capital, Vertex Ventures HC, Cowen Healthcare Investments, Alexandria Venture Investments and 5 others. 11 distinct backers are named across the disclosed rounds.

TORL BioTherapeutics at a glance

Total raised: $450M
Latest round: Series C
Latest round date: October 2025
Industry: Biotech
Headquarters: Culver City, California
Notable investors: Goldman Sachs Asset Management, Bristol Myers Squibb, Deep Track Capital, Vertex Ventures HC, Cowen Healthcare Investments, Alexandria Venture Investments, OCV Partners, Office of the Chief Investment Officer

Frequently asked about TORL BioTherapeutics funding

How much has TORL BioTherapeutics raised?: TORL BioTherapeutics has raised $450M in total disclosed funding across the rounds on record.
Who has invested in TORL BioTherapeutics?: Goldman Sachs Asset Management, Bristol Myers Squibb, Deep Track Capital, Vertex Ventures HC, Cowen Healthcare Investments, Alexandria Venture Investments are named among the investors backing TORL BioTherapeutics.
What was the latest TORL BioTherapeutics funding round?: The most recent disclosed round is a Series C, announced in October 2025.
Where is TORL BioTherapeutics based?: TORL BioTherapeutics is based in Culver City, California.
What sector does TORL BioTherapeutics operate in?: TORL BioTherapeutics is tracked under Biotech from Culver City, California, with $450M in disclosed funding.
When did TORL BioTherapeutics last raise?: The last disclosed TORL BioTherapeutics round closed in October 2025 at Series C.

Totals shown for TORL BioTherapeutics aggregate every disclosed round on file. To see how that compares, browse the Biotech companies in Culver City and the investors behind them below.

TORL BioTherapeutics Funding: $450M Raised, Series C (2025)

TORL BioTherapeutics funding overview

TORL BioTherapeutics at a glance

Frequently asked about TORL BioTherapeutics funding

Companies related to TORL BioTherapeutics (40)

Browse related funding lists (8)